1. Assist customers to complete the determination of starting materials and quickly complete the process development of RSMs and APIs, which has obvious advantages in the control of material costs;
2. Fast delivery of toxicology batches to meet challenging timelines, and develop control strategy for RSMs, intermediates and APIs;
3. Experienced in impurity control strategy, including impurity ID, preparation, and analytical methods development;
4. Experts in potential genotoxic impurity (PGI) control, from in silico screening to analytical methods development and validation;
5.Assist clients in completing US-China dual IND filings.